China NMPA Drug Inspection - Jilin Province Cross-Sea Biochemical Pharmaceutical Manufacturing Co., Ltd. - Ginkgo biloba leaf dispersible tablets
China NMPA drug inspection for Jilin Province Cross-Sea Biochemical Pharmaceutical Manufacturing Co., Ltd. published July 02, 2015. Drug: Ginkgo biloba leaf dispersible tablets. From June 16 to 25, 2015, China's State Food and Drug Administration (SFDA) conducted a special supervision and sampling
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jilin Province Cross-Sea Biochemical Pharmaceutical Manufacturing Co., Ltd. published July 02, 2015. Drug: Ginkgo biloba leaf dispersible tablets. From June 16 to 25, 2015, China's State Food and Drug Administration (SFDA) conducted a special supervision and sampling
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox